Correlation Between the Transient Elevation of Peripheral Eosinophil Count During Radiotherapy and Acute Diarrhea
- PMID: 35403139
- PMCID: PMC8988959
- DOI: 10.21873/cdp.10044
Correlation Between the Transient Elevation of Peripheral Eosinophil Count During Radiotherapy and Acute Diarrhea
Abstract
Background/aim: This study aimed to evaluate the association between the change in peripheral eosinophil count during postoperative pelvic radiotherapy and gastrointestinal (GI) toxicities in patients with cervical cancer.
Patients and methods: The medical records of 163 patients with cervical cancer who underwent postoperative concurrent chemoradiotherapy between 2000 and 2016 were analyzed.
Results: Among the peripheral blood cell counts, transient elevation of the eosinophil count was observed during radiotherapy. Of the 163 patients, 117 developed grade ≥2 diarrhea during radiotherapy, and 25 patients developed grade ≥2 late GI toxicities. In multivariate analysis, the maximum eosinophil count and age emerged as independent predictors of grade ≥2 acute diarrhea during radiotherapy, while bowel bag V 40 Gy and age were predictive of grade ≥2 late GI toxicities.
Conclusion: Early detection of transient elevation of eosinophil may facilitate early treatment of acute diarrhea during radiotherapy.
Keywords: Acute diarrhea; cervical neoplasm; eosinophil; late; postoperative; toxicity.
Copyright 2021, International Institute of Anticancer Research.
Conflict of interest statement
All Authors declare no conflicts of interest with regards to preparation and content of this article.
Figures


Similar articles
-
Normal tissue complication probability analysis of acute gastrointestinal toxicity in cervical cancer patients undergoing intensity modulated radiation therapy and concurrent cisplatin.Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):e81-6. doi: 10.1016/j.ijrobp.2011.12.012. Int J Radiat Oncol Biol Phys. 2012. PMID: 22516388
-
Reduced acute bowel toxicity in patients treated with intensity-modulated radiotherapy for rectal cancer.Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):1981-7. doi: 10.1016/j.ijrobp.2011.01.051. Epub 2011 Apr 7. Int J Radiat Oncol Biol Phys. 2012. PMID: 21477938
-
Dose-volume histogram predictors of chronic gastrointestinal complications after radical hysterectomy and postoperative concurrent nedaplatin-based chemoradiation therapy for early-stage cervical cancer.Int J Radiat Oncol Biol Phys. 2013 Mar 1;85(3):728-34. doi: 10.1016/j.ijrobp.2012.05.021. Epub 2012 Jun 23. Int J Radiat Oncol Biol Phys. 2013. PMID: 22727885
-
Predictors of acute toxicities during definitive chemoradiation using intensity-modulated radiotherapy for anal squamous cell carcinoma.Acta Oncol. 2016;55(2):208-16. doi: 10.3109/0284186X.2015.1043396. Epub 2015 May 18. Acta Oncol. 2016. PMID: 25984929 Free PMC article. Clinical Trial.
-
Pelvic Complications After Prostate Cancer Radiation Therapy and Their Management: An International Collaborative Narrative Review.Eur Urol. 2019 Mar;75(3):464-476. doi: 10.1016/j.eururo.2018.12.003. Epub 2018 Dec 17. Eur Urol. 2019. PMID: 30573316
References
-
- Peters WA 3rd, Liu PY, Barrett RJ 2nd, Stock RJ, Monk BJ, Berek JS, Souhami L, Grigsby P, Gordon W Jr, Alberts DS. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol. 2000;18(8):1606–1613. doi: 10.1200/JCO.2000.18.8.1606. - DOI - PubMed
-
- Isohashi F, Takano T, Onuki M, Arimoto T, Kawamura N, Hara R, Kawano Y, Ota Y, Inokuchi H, Shinjo H, Saito T, Fujiwara S, Sawasaki T, Ando K, Horie K, Okamoto H, Murakami N, Hasumi Y, Kasamatsu T, Toita T. A multi-institutional observational study on the effects of three-dimensional radiotherapy and weekly 40-mg/m2 cisplatin on postoperative uterine cervical cancer patients with high-risk prognostic factors. Int J Clin Oncol. 2019;24(5):575–582. doi: 10.1007/s10147-018-01380-z. - DOI - PMC - PubMed
-
- Isohashi F, Mabuchi S, Akino Y, Yoshioka Y, Seo Y, Suzuki O, Tamari K, Yoshino K, Sawada K, Ueda Y, Kobayashi E, Sumida I, Mizuno H, Okubo H, Kimura T, Ogawa K. Dose-volume analysis of predictors for chronic gastrointestinal complications in patients with cervical cancer treated with postoperative concurrent chemotherapy and whole-pelvic radiation therapy. J Radiat Res. 2016;57(6):668–676. doi: 10.1093/jrr/rrw037. - DOI - PMC - PubMed
-
- Isohashi F, Yoshioka Y, Mabuchi S, Konishi K, Koizumi M, Takahashi Y, Ogata T, Maruoka S, Kimura T, Ogawa K. Dose-volume histogram predictors of chronic gastrointestinal complications after radical hysterectomy and postoperative concurrent nedaplatin-based chemoradiation therapy for early-stage cervical cancer. Int J Radiat Oncol Biol Phys. 2013;85(3):728–734. doi: 10.1016/j.ijrobp.2012.05.021. - DOI - PubMed
-
- Isohashi F, Mabuchi S, Yoshioka Y, Seo Y, Suzuki O, Tamari K, Yamashita M, Unno H, Kinose Y, Kozasa K, Sumida I, Otani Y, Kimura T, Ogawa K. Intensity-modulated radiation therapy versus three-dimensional conformal radiation therapy with concurrent nedaplatin-based chemotherapy after radical hysterectomy for uterine cervical cancer: comparison of outcomes, complications, and dose-volume histogram parameters. Radiat Oncol. 2015;10:180. doi: 10.1186/s13014-015-0486-5. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources